Text this: Favorable Perioperative and Survival Outcomes After Resection of Borderline Resectable Pancreatic Cancer Treated With Neoadjuvant Stereotactic Radiation and Chemotherapy Compared With Upfront Pancreatectomy for Resectable Cancer.